Ocular Therapeutix
OCUL
7.23
-0.11
-1.50%
Ocular Therapeutix
US · OCUL
#2978 by market cap
Listed 1970
7.23
-0.11
-1.50%
Live - 5344 symbols - heartbeat 426s ago
· 2026-10-08 08:12
Pre-market
7.21
-0.28%
After-hours
7.25
+0.28%
Overnight
7.18
-0.69%
- Market cap
- 1.59B
- P/E (TTM)i
- -5.16
- P/Bi
- 3.05
- EPSi
- -1.42
- Div yieldi
- 0.00%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on OCUL?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
25.57 +253.7%
Price target rangecurrent 7.23
Low18.00
Avg25.57
High31.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Piper Sandler | -- | BUY | 31.00 |
| 2026-09-28 | Needham | -- | BUY | 18.00 |
| 2026-09-25 | William Blair | -- | BUY | -- |
| 2026-09-16 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-09-15 | William Blair | -- | BUY | -- |
| 2026-09-15 | BofA Securities | -- | BUY | 27.00 |
| 2026-08-26 | Piper Sandler | -- | BUY | 31.00 |
| 2026-08-20 | BofA Securities | -- | BUY | 27.00 |
| 2026-08-18 | Clear Street | -- | BUY | 28.00 |
| 2026-08-17 | William Blair | -- | BUY | -- |
| 2026-08-17 | Needham | -- | BUY | 18.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 27.00 |
| 2026-08-04 | Clear Street | -- | BUY | 28.00 |
| 2026-08-04 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-08-03 | TD Cowen | -- | BUY | 20.00 |
| 2026-08-03 | William Blair | -- | BUY | -- |
| 2026-08-03 | Needham | -- | BUY | 18.00 |
| 2026-08-03 | RBC Capital | -- | BUY | 30.00 |
| 2026-07-30 | RBC Capital | -- | BUY | 30.00 |
| 2026-06-22 | BofA Securities | -- | BUY | 27.00 |
| 2026-06-22 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-06-18 | William Blair | -- | BUY | -- |
| 2026-06-18 | Piper Sandler | -- | BUY | 31.00 |
| 2026-06-18 | Baird | -- | BUY | 30.00 |
| 2026-06-18 | Needham | -- | BUY | 18.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q1 | 2026-05-05 | -- | ±12.79% | -0.61% (in line) |
| 2025/Q3 | 2025-11-04 | -- | ±10.96% | -4.47% (in line) |
| 2025/Q2 | 2025-08-05 | -- | ±15.69% | -2.83% (in line) |
| 2025/Q1 | 2025-05-05 | -- | ±14.42% | -12.16% (in line) |
| 2024/Q4 | 2025-03-03 | -- | ±19.86% | -17.02% (in line) |
| 2024/Q3 | 2024-11-14 | -- | ±15.29% | -6.42% (in line) |
| 2024/Q2 | 2024-08-07 | -- | ±23.07% | +6.08% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±16.69% | -3.04% (in line) |
| 2023/Q4 | 2024-03-11 | After close | ±13.75% | -4.52% (in line) |
| 2023/Q3 | 2023-11-07 | After close | ±21.37% | -13.20% (in line) |
| 2023/Q2 | 2023-08-07 | After close | ±22.34% | -10.78% (in line) |
| 2023/Q1 | 2023-05-08 | After close | ±19.20% | +2.34% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:12:23 · For reference only, not investment advice and not tailored to your situation.